Report Detail
Global Dilated Cardiomyopathy Therapeutic Market Size, Status and Forecast 2019-2025
- RnM3627374 |
- 29 July, 2019 |
- Global |
- 93 Pages |
- QYResearch |
- Other
Dilated cardiomyopathy (DCM) is characterized by LV (left ventricular) or biventricular systolic dysfunction and dilation, not explained by abnormal loading conditions or coronary artery disease.
In 2018, the global Dilated Cardiomyopathy Therapeutic market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.
This report focuses on the global Dilated Cardiomyopathy Therapeutic status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Dilated Cardiomyopathy Therapeutic development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
The key players covered in this study
Array BioPharma, Inc.
AstraZeneca plc.
Celladon Corporation
GlaxoSmithKline plc
Janssen Pharmaceuticals, Inc. (J&J)
Merck & Co., Inc.
Novartis International AG
Pfizer, Inc.
Sanofi S.A.
Teva Pharmaceutical Industries Ltd.
Vericel Corporation
Market segment by Type, the product can be split into
Aldosterone antagonists
Angiotensin-converting enzyme (ACE) inhibitors
Angiotensin II receptor blockers (ARBs)
Beta-blockers
Market segment by Application, split into
Hospitals
Academic Institutions
Market segment by Regions/Countries, this report covers
North America
Europe
China
Japan
Southeast Asia
India
Central & South America
The study objectives of this report are:
To analyze global Dilated Cardiomyopathy Therapeutic status, future forecast, growth opportunity, key market and key players.
To present the Dilated Cardiomyopathy Therapeutic development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.
In this study, the years considered to estimate the market size of Dilated Cardiomyopathy Therapeutic are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Table of Contents
1 Report Overview
- 1.1 Study Scope
- 1.2 Key Market Segments
- 1.3 Players Covered
- 1.4 Market Analysis by Type
- 1.4.1 Global Dilated Cardiomyopathy Therapeutic Market Size Growth Rate by Type (2014-2025)
- 1.4.2 Aldosterone antagonists
- 1.4.3 Angiotensin-converting enzyme (ACE) inhibitors
- 1.4.4 Angiotensin II receptor blockers (ARBs)
- 1.4.5 Beta-blockers
- 1.5 Market by Application
- 1.5.1 Global Dilated Cardiomyopathy Therapeutic Market Share by Application (2019-2025)
- 1.5.2 Hospitals
- 1.5.3 Academic Institutions
- 1.6 Study Objectives
- 1.7 Years Considered
2 Global Growth Trends
- 2.1 Dilated Cardiomyopathy Therapeutic Market Size
- 2.2 Dilated Cardiomyopathy Therapeutic Growth Trends by Regions
- 2.2.1 Dilated Cardiomyopathy Therapeutic Market Size by Regions (2019-2025)
- 2.2.2 Dilated Cardiomyopathy Therapeutic Market Share by Regions (2014-2019)
- 2.3 Industry Trends
- 2.3.1 Market Top Trends
- 2.3.2 Market Drivers
- 2.3.3 Market Challenges
- 2.3.4 Porter’s Five Forces Analysis
3 Market Share by Key Players
- 3.1 Dilated Cardiomyopathy Therapeutic Market Size by by Players
- 3.1.1 Global Dilated Cardiomyopathy Therapeutic Revenue by by Players (2014-2019)
- 3.1.2 Global Dilated Cardiomyopathy Therapeutic Revenue Market Share by by Players (2014-2019)
- 3.1.3 Global Dilated Cardiomyopathy Therapeutic Market Concentration Ratio (CR5 and HHI)
- 3.2 Dilated Cardiomyopathy Therapeutic Key Players Head office and Area Served
- 3.3 Key Players Dilated Cardiomyopathy Therapeutic Product/Solution/Service
- 3.4 Date of Enter into Dilated Cardiomyopathy Therapeutic Market
- 3.5 Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Type and Application
- 4.1 Global Dilated Cardiomyopathy Therapeutic Market Size by Type (2014-2019)
- 4.2 Global Dilated Cardiomyopathy Therapeutic Market Size by Application (2014-2019)
5 North America
- 5.1 North America Dilated Cardiomyopathy Therapeutic Market Size (2014-2019)
- 5.2 Dilated Cardiomyopathy Therapeutic Key Players in North America
- 5.3 North America Dilated Cardiomyopathy Therapeutic Market Size by Type
- 5.4 North America Dilated Cardiomyopathy Therapeutic Market Size by Application
6 Europe
- 6.1 Europe Dilated Cardiomyopathy Therapeutic Market Size (2014-2019)
- 6.2 Dilated Cardiomyopathy Therapeutic Key Players in Europe
- 6.3 Europe Dilated Cardiomyopathy Therapeutic Market Size by Type
- 6.4 Europe Dilated Cardiomyopathy Therapeutic Market Size by Application
7 China
- 7.1 China Dilated Cardiomyopathy Therapeutic Market Size (2014-2019)
- 7.2 Dilated Cardiomyopathy Therapeutic Key Players in China
- 7.3 China Dilated Cardiomyopathy Therapeutic Market Size by Type
- 7.4 China Dilated Cardiomyopathy Therapeutic Market Size by Application
8 Japan
- 8.1 Japan Dilated Cardiomyopathy Therapeutic Market Size (2014-2019)
- 8.2 Dilated Cardiomyopathy Therapeutic Key Players in Japan
- 8.3 Japan Dilated Cardiomyopathy Therapeutic Market Size by Type
- 8.4 Japan Dilated Cardiomyopathy Therapeutic Market Size by Application
9 Southeast Asia
- 9.1 Southeast Asia Dilated Cardiomyopathy Therapeutic Market Size (2014-2019)
- 9.2 Dilated Cardiomyopathy Therapeutic Key Players in Southeast Asia
- 9.3 Southeast Asia Dilated Cardiomyopathy Therapeutic Market Size by Type
- 9.4 Southeast Asia Dilated Cardiomyopathy Therapeutic Market Size by Application
10 India
- 10.1 India Dilated Cardiomyopathy Therapeutic Market Size (2014-2019)
- 10.2 Dilated Cardiomyopathy Therapeutic Key Players in India
- 10.3 India Dilated Cardiomyopathy Therapeutic Market Size by Type
- 10.4 India Dilated Cardiomyopathy Therapeutic Market Size by Application
11 Central & South America
- 11.1 Central & South America Dilated Cardiomyopathy Therapeutic Market Size (2014-2019)
- 11.2 Dilated Cardiomyopathy Therapeutic Key Players in Central & South America
- 11.3 Central & South America Dilated Cardiomyopathy Therapeutic Market Size by Type
- 11.4 Central & South America Dilated Cardiomyopathy Therapeutic Market Size by Application
12 International Players Profiles
- 12.1 Array BioPharma, Inc.
- 12.1.1 Array BioPharma, Inc. Company Details
- 12.1.2 Company Description and Business Overview
- 12.1.3 Dilated Cardiomyopathy Therapeutic Introduction
- 12.1.4 Array BioPharma, Inc. Revenue in Dilated Cardiomyopathy Therapeutic Business (2014-2019))
- 12.1.5 Array BioPharma, Inc. Recent Development
- 12.2 AstraZeneca plc.
- 12.2.1 AstraZeneca plc. Company Details
- 12.2.2 Company Description and Business Overview
- 12.2.3 Dilated Cardiomyopathy Therapeutic Introduction
- 12.2.4 AstraZeneca plc. Revenue in Dilated Cardiomyopathy Therapeutic Business (2014-2019)
- 12.2.5 AstraZeneca plc. Recent Development
- 12.3 Celladon Corporation
- 12.3.1 Celladon Corporation Company Details
- 12.3.2 Company Description and Business Overview
- 12.3.3 Dilated Cardiomyopathy Therapeutic Introduction
- 12.3.4 Celladon Corporation Revenue in Dilated Cardiomyopathy Therapeutic Business (2014-2019)
- 12.3.5 Celladon Corporation Recent Development
- 12.4 GlaxoSmithKline plc
- 12.4.1 GlaxoSmithKline plc Company Details
- 12.4.2 Company Description and Business Overview
- 12.4.3 Dilated Cardiomyopathy Therapeutic Introduction
- 12.4.4 GlaxoSmithKline plc Revenue in Dilated Cardiomyopathy Therapeutic Business (2014-2019)
- 12.4.5 GlaxoSmithKline plc Recent Development
- 12.5 Janssen Pharmaceuticals, Inc. (J&J)
- 12.5.1 Janssen Pharmaceuticals, Inc. (J&J) Company Details
- 12.5.2 Company Description and Business Overview
- 12.5.3 Dilated Cardiomyopathy Therapeutic Introduction
- 12.5.4 Janssen Pharmaceuticals, Inc. (J&J) Revenue in Dilated Cardiomyopathy Therapeutic Business (2014-2019)
- 12.5.5 Janssen Pharmaceuticals, Inc. (J&J) Recent Development
- 12.6 Merck & Co., Inc.
- 12.6.1 Merck & Co., Inc. Company Details
- 12.6.2 Company Description and Business Overview
- 12.6.3 Dilated Cardiomyopathy Therapeutic Introduction
- 12.6.4 Merck & Co., Inc. Revenue in Dilated Cardiomyopathy Therapeutic Business (2014-2019)
- 12.6.5 Merck & Co., Inc. Recent Development
- 12.7 Novartis International AG
- 12.7.1 Novartis International AG Company Details
- 12.7.2 Company Description and Business Overview
- 12.7.3 Dilated Cardiomyopathy Therapeutic Introduction
- 12.7.4 Novartis International AG Revenue in Dilated Cardiomyopathy Therapeutic Business (2014-2019)
- 12.7.5 Novartis International AG Recent Development
- 12.8 Pfizer, Inc.
- 12.8.1 Pfizer, Inc. Company Details
- 12.8.2 Company Description and Business Overview
- 12.8.3 Dilated Cardiomyopathy Therapeutic Introduction
- 12.8.4 Pfizer, Inc. Revenue in Dilated Cardiomyopathy Therapeutic Business (2014-2019)
- 12.8.5 Pfizer, Inc. Recent Development
- 12.9 Sanofi S.A.
- 12.9.1 Sanofi S.A. Company Details
- 12.9.2 Company Description and Business Overview
- 12.9.3 Dilated Cardiomyopathy Therapeutic Introduction
- 12.9.4 Sanofi S.A. Revenue in Dilated Cardiomyopathy Therapeutic Business (2014-2019)
- 12.9.5 Sanofi S.A. Recent Development
- 12.10 Teva Pharmaceutical Industries Ltd.
- 12.10.1 Teva Pharmaceutical Industries Ltd. Company Details
- 12.10.2 Company Description and Business Overview
- 12.10.3 Dilated Cardiomyopathy Therapeutic Introduction
- 12.10.4 Teva Pharmaceutical Industries Ltd. Revenue in Dilated Cardiomyopathy Therapeutic Business (2014-2019)
- 12.10.5 Teva Pharmaceutical Industries Ltd. Recent Development
- 12.11 Vericel Corporation
13 Market Forecast 2019-2025
- 13.1 Market Size Forecast by Product (2019-2025)
- 13.2 Market Size Forecast by Application (2019-2025)
- 13.3 Market Size Forecast by Regions
- 13.4 North America
- 13.5 Europe
- 13.6 China
- 13.7 Japan
- 13.8 Southeast Asia
- 13.9 India
- 13.10 Central & South America
14 Analyst's Viewpoints/Conclusions
15 Appendix
- 15.1 Research Methodology
- 15.1.1 Methodology/Research Approach
- 15.1.1.1 Research Programs/Design
- 15.1.1.2 Market Size Estimation
- 15.1.1.3 Market Breakdown and Data Triangulation
- 15.1.2 Data Source
- 15.1.2.1 Secondary Sources
- 15.1.2.2 Primary Sources
- 15.1.1 Methodology/Research Approach
- 15.2 Disclaimer
Summary:
Get latest Market Research Reports on Dilated Cardiomyopathy Therapeutic. Industry analysis & Market Report on Dilated Cardiomyopathy Therapeutic is a syndicated market report, published as Global Dilated Cardiomyopathy Therapeutic Market Size, Status and Forecast 2019-2025. It is complete Research Study and Industry Analysis of Dilated Cardiomyopathy Therapeutic market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
